DK

Dileep Kumar Reddy Palagiri

Active Director Additional Director DIN 11127829
DIN 11127829 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Dileep Kumar Reddy Palagiri

Data last updated:

Dileep Kumar Reddy Palagiri is an Additional Director at Gsr Life Sciences Private Limited (since 2025).

DIN 11127829
Primary Designation Additional Director
First Appointment 31 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gsr Life Sciences Private Limited U46497TS2024PTC191996
Additional Director31 May 20252024Active

Board colleagues of Dileep Kumar Reddy Palagiri

NameDINCompanyDesignation
Sanath Kumar Reddy Mamidi10874542Gsr Life Sciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gsr Life Sciences Private Limited
Premium access

Shareholding and investment profile for Dileep Kumar Reddy Palagiri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dileep Kumar Reddy Palagiri

Dileep Kumar Reddy Palagiri currently holds 1 directorship: Gsr Life Sciences Private Limited (Additional Director, since 31 May 2025).

Dileep Kumar Reddy Palagiri was first appointed on 31 May 2025 as Additional Director at Gsr Life Sciences Private Limited.

The current boards of Dileep Kumar Reddy Palagiri's companies include Sanath Kumar Reddy Mamidi (Gsr Life Sciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available